What is the Healthcare sector?
The global Health Care sector spans pharmaceuticals, biotechnology, medical devices, diagnostics, and services. Ageing populations, innovation pipelines, and reimbursement policy drive long-run demand. The table above lists health care companies in our dataset — from large-cap pharma and device leaders to mid-cap biotech.
Key drivers for Healthcare sector stocks in 2026
Demographics and chronic disease burden
Ageing populations in developed markets support sustained demand for therapies, devices, and services.
Innovation and pipeline execution
Patent cliffs, trial readouts, and regulatory approvals move individual stock prices — especially in biotech.
Reimbursement and pricing policy
Government and insurer reimbursement in the US, Europe, and Asia shapes revenue for drugs and devices.
GLP-1 and therapeutic innovation waves
Obesity, oncology, and immunology breakthroughs reallocate market share and capex across sub-sectors.
Risks for Healthcare sector investors
Biotech carries binary clinical risk. Large pharma faces patent cliffs and pricing pressure. Device makers depend on hospital capex cycles. Regulatory rejection or safety issues can devastate individual names. Verify each company's pipeline and geography in the table.
How to invest in Healthcare sector stocks
Large-cap pharma and device franchises offer core exposure. Biotech adds event-driven risk-reward. Global health care ETFs diversify single-trial risk. Use the table to see which names dominate market cap in our current coverage.
How Tickerplace ranks Healthcare sector stocks
Tickerplace ranks every company in the live table above by market capitalisation, trading liquidity, and intrinsic value. Rankings reflect our current multi-market dataset — which may include US, Australian, and other listed companies — and update as coverage expands. Click any ticker to open its full valuation page.